期刊
JOURNAL OF AFFECTIVE DISORDERS
卷 233, 期 -, 页码 36-44出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jad.2017.08.087
关键词
-
资金
- NARSAD Distinguished Investigator Award
- Canadian Institute of Health Research (CIHR) [FDN148374, EGM141899]
- FRQS through the Quebec Network on Suicide, Mood Disorders and Related Disorders
Background: Antidepressant treatment is associated with a high rate of poor response, and thus, biomarker development is warranted. Methods: We aimed to synthesize studies investigating gene expression, small RNAs, and epigenomic biomarkers of antidepressant response. We conducted a narrative review of the literature. Results: Firstly, we detailed the challenges involved, in terms of biological tissues, relevant study time frames, and mandatory statistical tools. Secondly we synthesized results obtained in gene expression studies, focusing mainly on genome-wide studies, particularly small non-coding RNA, including micro-RNA and other small RNA species. In addition, we reviewed the potential biomarkers of antidepressant response arising from studies investigating DNA methylation variation and histone modifications. Limitations: We did not conduct a meta-analysis due to the heterogeneity of the study. Conclusion: Although promising, the field of gene expression and epigenomic biomarkers of antidepressant response is still in its infancy, and needs further development to define useful biomarkers in clinical practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据